MedTrace Logo

Probiotics and Endotoxemia

NCT01176942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-12-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether probiotic treatment of overweight volunteers consuming high fat diet is able to reduce plasma lipopolysaccharide concentration.

Conditions

  • Metabolic Endotoxemia
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Probiotic bacterium Bifidobacterium lactis

Probiotic placebo controlled intervention

Sponsors & Collaborators

  • Danisco

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-12-31
Completion
2011-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01176942 on ClinicalTrials.gov